JOHNSON & JOHNSON |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 136.3 EUR | -0.39% |
|
-1.73% | -3.74% |
| 06-28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
| 06-28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
